{"name":"PRM Pharma, LLC","slug":"prm-pharma-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxQLVNGVENfelpiMV91MmJyMEREMHNRVE90VV9WN29DQV9KcnAxd21LVWFkUGRzODJuOEtJSFRFNl9ZaG10cWVFZHNVSjJDeWV4QkZlU2NCMmlSUmwxZEtCWllMajFYSDQzZEFpXzZVLWNXVWRQSDhGZ1B3eGhhTzBTYmVWVnlMVmNpbVNfQTFGR1hQNzJaLUlxclY1NjRZaDJjOUZDdVFvWjNSaGRsV1gzSldoRjg3SUZJUlhQNUlyb1FTbmp2Ym5MQ09KWGUxa1QtYjRVaWdZbkppbHhNR1YwcVh1dEMxcFdBUG93WjBtbTc1TU4zOTZIQmxlVkZhSmlSREpQeGxvY1dYd19pdDVWMEppTS1DbUk4eUU3blRLa0tBSm1LSlhpQ2VJS1dJSDlla3Y5VGZRNldnNHpyRmFnSzRQa1ZDcUVfU3c?oc=5","date":"2025-11-07","type":"regulatory","source":"prnewswire.com","summary":"PRM Pharma Announces Nationwide Availability of HemiClor® (Chlorthalidone) 12.5 mg: The First FDA-Approved Low-Dose Chlorthalidone Tablet Aligned With Hypertension Guidelines - prnewswire.com","headline":"PRM Pharma Announces Nationwide Availability of HemiClor® (Chlorthalidone) 12.5 mg: The First FDA-Approved Low-Dose Chlo","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOM3JYN1N4bFdTM1dscEhiS09WLVByam5WY1VBaDJ5NEVjWXJDelA1YTFpdzlRQktYeHB2bmhzZ1B5SEVDRXRSM1h3cXptb3d0ZDdnd2huQWw5LUU4TjR0ZnNUSUk0cWt0UWp1Q050MnBsZ1E1LXJuTkh1OU5jRzZLS2pzQVhBVjhSYzgw?oc=5","date":"2025-06-24","type":"pipeline","source":"Yahoo Finance","summary":"A New Chapter in the Story of Chlorthalidone: Low-Dose HEMICLOR® Now Available in Pharmacies Nationwide - Yahoo Finance","headline":"A New Chapter in the Story of Chlorthalidone: Low-Dose HEMICLOR® Now Available in Pharmacies Nationwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPRUU3bHZoanNwTVgwQ2E0Qzk3VE1vaHNpd0hhVlExa29CWE1OM1FDVW5IMUVQMzRxNFN2cW94Z3V6SFdCc2l0eWhiZUdtR0tnM3NUckNpVjRzUGR4V0c3ZTdGMmhJTzdCbGFNMVlHMU12RFhYWHlhdUpOYTZ4NFVZbndVREN5WVBrbUdEd2JPMUd2R0FHejc5YzlkS3kweFhTa3R4WWQxeTg3di1pLUdZLVdFTGd2VV9CSFRtSXJBWmtEdkE?oc=5","date":"2025-05-08","type":"regulatory","source":"Patient Care Online","summary":"FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults - Patient Care Online","headline":"FDA Greenlights Low-Dose Clorthalidone (12.5 mg) for Treatment of Hypertension in Adults","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOalZ2MG5zY3RMeFRiRnhJcFJfSnFqVXExWE5wRTFaNld4bGVxYnI1ZXk2b3VkWEF4bzR6b0VBa3lOWGl6TE9Db0x2S0lZVlhnSGdwbkJVR3NMdGR5MXRHLUFHdXE1Um53bzN4Y1YzaDRDWlpJODFTbGJjcnFVM2NlV2NKM0t2M3l2STZwNUVzeHBUeFk?oc=5","date":"2025-05-06","type":"regulatory","source":"HCPLive","summary":"FDA Approves 12.5 mg Chlorthalidone Tablets for Hypertension - HCPLive","headline":"FDA Approves 12.5 mg Chlorthalidone Tablets for Hypertension","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxQeHhISHVyb2Z5d2h0aGoyZW4takJhLTlQaDlYbFFlaTRvMnBrN3h6cEttemhWelM0SzRkRFlzVlkzTkdET1dqb2xZcVdjZ0pKWGZIVnd0QnBDRHJjN0J3WXZmaWRpU0g4VndCYk9zSE94dF80VWNWX01MYXpJci02SFozdHlOdlR2TkM0ckNpdjBzVHE5U2hVUzc0U0dMODBXZkNYY08xOFh1OE53eWRRYi03cUIwQlh3d0JvTU41djhNMm9Mc3hBelZldmRETjlQd3ptNmlkY2RuQm9zR1F4WlMzeVQyUnhxeDdBSUNSbjRJX1NLVjI0ZEs0bmY3dWh4dDd1TFZKbjlpNTlIeXdqdm9PWG1mS3hEMTNTTmRjZw?oc=5","date":"2025-01-20","type":"trial","source":"GlobeNewswire","summary":"Advancements in Ocular Hypertension Clinical Trial Pipeline - GlobeNewswire","headline":"Advancements in Ocular Hypertension Clinical Trial Pipeline","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2023-07-19","type":"pipeline","source":"prnewswire.com","summary":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Bayer, Merck, Insmed, Acceleron, AbbVie, Alnylam, Apnimed, AstraZeneca, Gossamer B","headline":"Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis, Ba","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE55ZGJBc2dUOVJKeFhUVTdNcF9nekwzdzB6LWV2aHZVNzh1Vk5xSUtJWU0wSHNIYU8wVHNkWkhPUkhlYnpVZHVXN3lSczFCcGtlU1NtMjJHZV92dUE?oc=5","date":"2008-02-08","type":"trial","source":"Nature","summary":"The spectrum of endometrial pathology induced by progesterone receptor modulators - Nature","headline":"The spectrum of endometrial pathology induced by progesterone receptor modulators","sentiment":"positive"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}